32
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Biomedical applications of three‐dimensional bioprinted craniofacial tissue engineering

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Anatomical complications of the craniofacial regions often present considerable challenges to the surgical repair or replacement of the damaged tissues. Surgical repair has its own set of limitations, including scarcity of the donor tissues, immune rejection, use of immune suppressors followed by the surgery, and restriction in restoring the natural aesthetic appeal. Rapid advancement in the field of biomaterials, cell biology, and engineering has helped scientists to create cellularized skeletal muscle‐like structures. However, the existing method still has limitations in building large, highly vascular tissue with clinical application. With the advance in the three‐dimensional (3D) bioprinting technique, scientists and clinicians now can produce the functional implants of skeletal muscles and bones that are more patient‐specific with the perfect match to the architecture of their craniofacial defects. Craniofacial tissue regeneration using 3D bioprinting can manage and eliminate the restrictions of the surgical transplant from the donor site. The concept of creating the new functional tissue, exactly mimicking the anatomical and physiological function of the damaged tissue, looks highly attractive. This is crucial to reduce the donor site morbidity and retain the esthetics. 3D bioprinting can integrate all three essential components of tissue engineering, that is, rehabilitation, reconstruction, and regeneration of the lost craniofacial tissues. Such integration essentially helps to develop the patient‐specific treatment plans and damage site‐driven creation of the functional implants for the craniofacial defects. This article is the bird's eye view on the latest development and application of 3D bioprinting in the regeneration of the skeletal muscle tissues and their application in restoring the functional abilities of the damaged craniofacial tissue. We also discussed current challenges in craniofacial bone vascularization and gave our view on the future direction, including establishing the interactions between tissue‐engineered skeletal muscle and the peripheral nervous system.

          Related collections

          Most cited references287

          • Record: found
          • Abstract: found
          • Article: not found

          Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

          Successful reprogramming of differentiated human somatic cells into a pluripotent state would allow creation of patient- and disease-specific stem cells. We previously reported generation of induced pluripotent stem (iPS) cells, capable of germline transmission, from mouse somatic cells by transduction of four defined transcription factors. Here, we demonstrate the generation of iPS cells from adult human dermal fibroblasts with the same four factors: Oct3/4, Sox2, Klf4, and c-Myc. Human iPS cells were similar to human embryonic stem (ES) cells in morphology, proliferation, surface antigens, gene expression, epigenetic status of pluripotent cell-specific genes, and telomerase activity. Furthermore, these cells could differentiate into cell types of the three germ layers in vitro and in teratomas. These findings demonstrate that iPS cells can be generated from adult human fibroblasts.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The basics of epithelial-mesenchymal transition.

            The origins of the mesenchymal cells participating in tissue repair and pathological processes, notably tissue fibrosis, tumor invasiveness, and metastasis, are poorly understood. However, emerging evidence suggests that epithelial-mesenchymal transitions (EMTs) represent one important source of these cells. As we discuss here, processes similar to the EMTs associated with embryo implantation, embryogenesis, and organ development are appropriated and subverted by chronically inflamed tissues and neoplasias. The identification of the signaling pathways that lead to activation of EMT programs during these disease processes is providing new insights into the plasticity of cellular phenotypes and possible therapeutic interventions.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              3D bioprinting of tissues and organs.

              Additive manufacturing, otherwise known as three-dimensional (3D) printing, is driving major innovations in many areas, such as engineering, manufacturing, art, education and medicine. Recent advances have enabled 3D printing of biocompatible materials, cells and supporting components into complex 3D functional living tissues. 3D bioprinting is being applied to regenerative medicine to address the need for tissues and organs suitable for transplantation. Compared with non-biological printing, 3D bioprinting involves additional complexities, such as the choice of materials, cell types, growth and differentiation factors, and technical challenges related to the sensitivities of living cells and the construction of tissues. Addressing these complexities requires the integration of technologies from the fields of engineering, biomaterials science, cell biology, physics and medicine. 3D bioprinting has already been used for the generation and transplantation of several tissues, including multilayered skin, bone, vascular grafts, tracheal splints, heart tissue and cartilaginous structures. Other applications include developing high-throughput 3D-bioprinted tissue models for research, drug discovery and toxicology.
                Bookmark

                Author and article information

                Contributors
                nitin.charbe@tamu.edu
                m.tambuwala@ulster.ac.uk
                Journal
                Bioeng Transl Med
                Bioeng Transl Med
                10.1002/(ISSN)2380-6761
                BTM2
                Bioengineering & Translational Medicine
                John Wiley & Sons, Inc. (Hoboken, USA )
                2380-6761
                10 May 2022
                January 2023
                : 8
                : 1 ( doiID: 10.1002/btm2.v8.1 )
                : e10333
                Affiliations
                [ 1 ] Irma Lerma Rangel College of Pharmacy Texas A&M Health Science Center Kingsville Texas USA
                [ 2 ] School of Pharmacy and Pharmaceutical Science Ulster University Coleraine UK
                [ 3 ] Department of Pharmacy Dadasaheb Balpande College of Pharmacy Nagpur India
                [ 4 ] Department of Genetics and Bioengineering, Faculty of Engineering and Natural Sciences International University of Sarajevo Sarajevo Bosnia and Herzegovina
                [ 5 ] Departamento de Quimica Orgánica, Facultad de Química y de Farmacia Pontificia Universidad Católica de Chile Santiago Chile
                [ 6 ] Institute for Biological and Medical Engineering, Schools of Engineering, Medicine and Biological Sciences Pontificia Universidad Católica de Chile Santiago Chile
                [ 7 ] School of Pharmaceutical Sciences Lovely Professional University Phagwara India
                [ 8 ] Department of Pharmaceutical Chemistry R.C. Patel Institute of Pharmaceutical Education and Research Dhule India
                [ 9 ] Faculty of Pharmacy, Department of Pharmaceutical Sciences Yarmouk University Irbid Jordan
                [ 10 ] Pharmacological and Diagnostic Research Centre, Faculty of Pharmacy Al‐Ahliyya Amman University Amman Jordan
                [ 11 ] Biomaterials and Bioengineering Lab Translational Research Centre San Alberto Magno Catholic University of Valencia San Vicente Mártir Valencia Spain
                Author notes
                [*] [* ] Correspondence

                Nitin Bharat Charbe, Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, 1010 West Avenue B, MSC 131, Kingsville, TX 78363, USA.

                Email: nitin.charbe@ 123456tamu.edu

                Murtaza Tambuwala, School of Pharmacy and Pharmaceutical Science, Ulster University, Coleraine, Northern Ireland BT52 1SA, UK.

                Email: m.tambuwala@ 123456ulster.ac.uk

                Author information
                https://orcid.org/0000-0001-8499-9891
                https://orcid.org/0000-0001-6542-2464
                https://orcid.org/0000-0002-9953-3848
                Article
                BTM210333
                10.1002/btm2.10333
                9842068
                36684092
                3155a1b3-2a9d-45c3-b360-8dcc3c4a2e44
                © 2022 The Authors. Bioengineering & Translational Medicine published by Wiley Periodicals LLC on behalf of American Institute of Chemical Engineers.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 12 April 2022
                : 14 February 2022
                : 15 April 2022
                Page count
                Figures: 4, Tables: 2, Pages: 32, Words: 31232
                Categories
                Review Article
                Review Articles
                Custom metadata
                2.0
                January 2023
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.3 mode:remove_FC converted:16.01.2023

                3d bioprinting,bioengineering,biomaterials,craniofacial tissue complex,soft tissues

                Comments

                Comment on this article